US Bancorp
ETON icon

US Bancorp’s Eton Pharmaceutcials ETON Stock Holding History

US Bancorp’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688 Hold
19
– – ﹤0.01% 4026
2026
Q1 		$469 Sell
19
-35
-65% -$612 ﹤0.01% 4012
2025
Q4 		$913 Buy
+54
New +$950 ﹤0.01% 3869
2023
Q4 		– Sell
-805
Closed -$3.36K – 4034
2023
Q3 		$3.36K Buy
+805
New +$3.11K ﹤0.01% 3548

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

US Bancorp's ETON Position: Q2 2026 in Review

US Bancorp held its Eton Pharmaceutcials (ETON) position steady in Q2 2026 at 19 shares worth $688. The position accounts for ﹤0.01% of the portfolio, ranked #4026.

US Bancorp first reported a position in ETON in Q3 2023 and has held it in 4 quarters since. The position peaked at $3.36K in Q3 2023. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • US Bancorp held 19 shares of Eton Pharmaceutcials worth $688 as of Q2 2026.
  • US Bancorp left its Eton Pharmaceutcials share count unchanged in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4026 holding.
  • US Bancorp first reported a position in Eton Pharmaceutcials in Q3 2023 and has held it in 4 quarters since.
  • US Bancorp's Eton Pharmaceutcials position peaked at $3.36K in Q3 2023.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.